Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Coron Artery Dis ; 20(2): 100-5, 2009 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19293667

RESUMO

OBJECTIVE: To delineate the effects of extracorporeal bypass on biomarkers of hemostasis, fibrinolysis, and inflammation and clinical sequelae. METHODS: Patients were assigned prospectively and randomly to either on-pump (n=41) or off-pump (n=51) coronary bypass surgery. The concentrations of C-reactive protein, fibrinogen, D-dimer, and plasminogen activator inhibitor type-1 in blood were quantified before and after (1 and 24 h) surgery. Similar surgical and anesthetic procedures were used for both groups. Clinical events were assessed during initial hospitalization and at the end of 1 year. RESULTS: The concentrations of plasminogen activator inhibitor type-1 and D-dimer were greater compared with preoperative values 1 and 24 h after surgery in both groups, but their concentrations increased to a greater extent 24 h after surgery in the on-pump group (P<0.01). The concentration of C-reactive protein did not change appreciably immediately after surgery in either group but increased in a parallel manner 24 h after either on-pump or off-pump surgery (P<0.01). Bypass surgery in the on-pump group was associated with greater blood loss during surgery and more bleeding after surgery (P< or =0.01). The incidence of all other complications was similar in the two groups. CONCLUSION: On-pump surgery was associated with biochemical evidence of a prothrombotic state early after surgery but no greater incidence of thrombotic events was observed. The prothrombotic state might be a consequence of extracorporeal bypass, compensation in response to more bleeding, or both in patients undergoing on-pump surgery.


Assuntos
Perda Sanguínea Cirúrgica/prevenção & controle , Ponte Cardiopulmonar/efeitos adversos , Ponte de Artéria Coronária sem Circulação Extracorpórea/efeitos adversos , Ponte de Artéria Coronária/efeitos adversos , Doença da Artéria Coronariana/cirurgia , Hemostasia , Hemorragia Pós-Operatória/prevenção & controle , Trombose/sangue , Idoso , Biomarcadores/sangue , Proteína C-Reativa/metabolismo , Doença da Artéria Coronariana/sangue , Feminino , Produtos de Degradação da Fibrina e do Fibrinogênio/metabolismo , Fibrinogênio/metabolismo , Fibrinólise , Humanos , Mediadores da Inflamação/sangue , Masculino , Pessoa de Meia-Idade , Inibidor 1 de Ativador de Plasminogênio/sangue , Hemorragia Pós-Operatória/sangue , Hemorragia Pós-Operatória/etiologia , Estudos Prospectivos , Trombose/etiologia , Fatores de Tempo , Resultado do Tratamento
2.
Buenos Aires; Kargieman; 1994. 309 p. (112933).
Monografia | BINACIS | ID: bin-112933
3.
Buenos Aires; Kargieman; 1994. 309 p. (112423).
Monografia | BINACIS | ID: bin-112423
4.
Buenos Aires; Kargieman; 1994. 309 p. (112422).
Monografia | BINACIS | ID: bin-112422
5.
7.
West Indian med. j ; 35(3): 200-2, Sept. 1986.
Artigo em Inglês | MedCarib | ID: med-11575

RESUMO

A few scattered reports have appeared in the literature in the last few years suggesting that focal and segmental glomerulosclerosis may be associated with the acquired immunodeficiency syndrome, leading to rapid deterioration of renal function with uraemia. This communication describes the first such case seen at Port-of-Spain General Hospital, Trinidad (AU)


Assuntos
Adulto , Humanos , Masculino , Síndrome da Imunodeficiência Adquirida/complicações , Glomerulonefrite/etiologia , Glomerulosclerose Segmentar e Focal/diagnóstico , Trinidad e Tobago
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA